Is Xcite Energy Limited A Better Buy Than Ophir Energy Plc, LGO Energy PLC, Ithaca Energy Inc. & Petrofac Limited?

Xcite Energy Limited (LON:XEL), Ophir Energy Plc (LON:OPHR), LGO Energy PLC (LON:LGO), Ithaca Energy Inc. (LON:IAE) and Petrofac Limited (LON:PFC) are under the spotlight.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Xcite Energy (LSE: XEL) released its second-quarter trading update earlier this week — there wasn’t much in it, to be honest. So I have looked for value elsewhere in the oil and gas world. 

I Won’t Buy Xcite & Ophir

Fossil fuel explorer Xcite Energy is certainly a riskier bet than, say, $1bn market cap Ophir Energy (LSE: OPHR) — yet neither stock is an obvious buy for me. Xcite, whose market cap is less than £100m, is down 20% this year, but the drop in its cash pile is more revealing than its subdued stock performance.

It reported cash of $34.4m as at 30 June 2015, down from $50m at the end of December and down from $70m at the end of June. That’s priced in a price-to-book value (P/BV) at about 0.35x, which is pretty low, the bulls may well argue!

Should you invest £1,000 in Phoenix Group Holdings Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Phoenix Group Holdings Plc made the list?

See the 6 stocks

Management believes it is making progress “despite the industry environment remaining challenging with the oil price recently falling below $50 per barrel, development budgets remaining under pressure, projects deferred and an increasing number of North Sea assets being put up for sale as oil companies seek to realign their portfolios”. But what does that mean for shareholders? 

The bears could point out that Xcite is burning about $8m of cash each quarter, while its debt load determines high interest costs. If I were keen to buy a value stock in the oil space, I’d certainly need more evidence to invest in XEL, and my approach would be similar with regard to Ophir, whose P/BV is about 0.5x.

Ophir boasts a much stronger cash position than Xcite: it announced earlier this month to have increased its full-year guidance for production as well as much lower capital expenditure. Management is incredibly bullish about the outlook for shareholders on the back of efficiency measures and access to cash reserves, which could even allow Ophir to pursue acquisitions. 

An upbeat view on Ophir’s prospects makes sense if you compare Ophir to a stretched oil player such as  Ithaca Energy (LSE: IAE), for instance, but Ophir shares have fallen almost 40% this year — and they are down for good reasons, including the loss of a key shareholder such as Kulczyk Entities, which sold 56.6m shares at 140p apiece for about £79m earlier this year.

As it turned out, that was a great trade, and one executed at 60% premium to Ophir’s current market value!

LGO & Petrofac Are More Attractive Than Ithaca

I’d certainly avoid Ithaca, whose assets base is less important than its financing needs. Its stock is down 40% this year; plunging revenues and rising leverage is exactly what I’d expect from a company whose market cap is less than $150m, but whose enterprise value, which includes net debt, is about $1bn.

I’d rather choose LGO Energy (LSE: LGO) if I were to take any risk in the sector. Its shares trade at 1.3p, having lost 65% of value this year. That said, the outlook for its Goudron field in Trinidad isn’t too bad following its recent production tests. 

In other news, LGO recently said that it was aware of the “misleading allegation made by Trinity Exploration & Production in its recent Q2 2015 (…) concerning the Sale and Purchase Agreement signed in 2014 with respect to the Tabaquite Block,” and “refute in its entirety Trinity’s claim that LGO is in breach of the SPA“.

Finally, one of my favourite oil picks: Petrofac (LSE: PFC)!

Its interim results for the six months ended 30 June were released today, and showed a 25% growth rate in revenues. 

Its earnings growth profile were less appealing, but as the group said, “net profit (is) significantly weighted to 2H 2015,”  and success in “new orders (…) with around US$6bn of order intake secured in the year to date in our core markets” combine with a healthy pipeline of bidding opportunities — all of which should guarantee a steep growth rate in revenues this year. 

Petrofac remains an enticing yield play and it expects significant savings from cost efficiency measures, which renders its relative valuation of 14.5x 2105 earnings more appealing. 

Like buying £1 for 31p

This seems ridiculous, but we almost never see shares looking this cheap. Yet this Share Advisor pick has a price/book ratio of 0.31. In plain English, this means that investors effectively get in on a business that holds £1 of assets for every 31p they invest!

Of course, this is the stock market where money is always at risk — these valuations can change and there are no guarantees. But some risks are a LOT more interesting than others, and at The Motley Fool we believe this company is amongst them.

What’s more, it currently boasts a stellar dividend yield of around 10%, and right now it’s possible for investors to jump aboard at near-historic lows. Want to get the name for yourself?

See the full investment case

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK owns and has recommended Petrofac. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

We think earning passive income has never been easier

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

More on Investing Articles

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

£10,000 invested in Tesco shares just a fortnight ago is already worth…

Tesco shares went through a sharp wobble a couple of weeks ago, but here's a look at what's happened to…

Read more »

Young female analyst working at her desk in the office
Investing Articles

9.6% yield! Here’s the dividend forecast for Glencore shares to 2027!

At nearly 10%, Glencore shares have one of the largest dividend yields on the FTSE 100. Here's why they could…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

£20,000 Stocks and Shares ISA: how long would it take to reach £1 million?

This writer considers how long it would take an investor to reach a seven-figure sum by maxing out their Stocks…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

UK bonds: a once-in-a-decade passive income opportunity?

Gilts are offering some very attractive yields at the moment. But Stephen Wright thinks passive income investors could still do…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

Down 99%, this stock has been crushed by AI and is now a penny share!

Chegg has gone from being a fast-growth tech stock to a penny share trading for less than $1 in the…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Could this rapidly growing coffee stock be the next Warren Buffett-style winner?

Discover why a fast-growing US coffee chain could be the next big US growth stock, with similarities to stocks picked…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

2 high-yielding dividend stocks I continue to double down on

Andrew Mackie explores two FTSE 350 high-yielding dividend stocks he's been snapping up in the last few weeks for his…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

Why did the AstraZeneca share price just fall, and what should we do?

The AstraZeneca share price just took a hit as President Trump announced a price war against the US pharmaceutical industry.

Read more »